T/CACM 1398-2022 Active Group standards

T/CACM 1398-2022 Pathological myopia macular hemorrhage Chinese diagnosis and treatment guidelines

T/CACM 1398-2022 Pathological myopia macular hemorrhage Chinese diagnosis and treatment guidelines

Publish Date: 2022-06-02 Implement Date: 2022-06-10 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Download

Basic Information

Standard Code: T/CACM 1398-2022
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2022-06-02
Implement Date: 2022-06-10
Pages: 15 pages

Scope

Main technical content: Preface II Introduction III 1 Scope 2 Normative reference documents 3 Terms and definitions 4 Epidemiology 5 Etiology and pathogenesis 6 Symptoms 6.1 Overview 6.2 Yin deficiency with fire hyperactivity syndrome 6.3 Qi deficiency with blood stasis syndrome 6.4 Qi stagnation and blood stasis syndrome 6.5 Liver depression with fire generation syndrome 6.6 Kidney deficiency with blood stasis syndrome 7 Diagnosis 7.1 Western medical clinical classification 7.2 Clinical characteristics 7.3 Ophthalmological examination 8 Treatment 8.1 Treatment principles 8.2 Pathological myopia with retinal fissure-like hemorrhage treatment 8.3 Pathological myopia with CNV-type macular hemorrhage treatment 9 Prevention and care 9.1 Overview 9.2 Health education 9.3 Daily life Appendix A (Informative) GRADE evidence certainty grading and recommendation strength Appendix B (Informative) 2018 Myopia Macular Lesion ATN Classification System Appendix C (Informative) Summary of recommendations 10 References

Development Information

Pages: 15 pages

Related Standards

Contact Us